Hexpol TPE is investing 57 million SEK ($5.6 million) at its facility in Åmål, Sweden, to support increasing demand for thermoplastic elastomers (TPEs) and satisfy evolving market requirements, the company announced today. The investment will expand production capacity and ensure compliance with product safety standards across its materials portfolio.
Hexpol TPE specializes in TPE compounds for sensitive and regulated applications, such as medical devices, toys, consumer products, automotive components, and food-contact packaging. Sustainability and bio-based materials are also driving the investment, said the company.
A new facility currently under construction will be dedicated to medical production, with strict cleanliness, traceability, and reproducibility controls. It has been designed to minimize contamination risks and will house a new twin-screw compounding line with gravimetric feeders and advanced monitoring systems. Construction is expected to be completed by the fall of 2022.
Hexpol TPE produced its first medical compounds in the 1990s and launched the Mediprene range of TPEs for medical applications in 2004. It was the first TPE compounder in Europe to gain ISO 13485 certification in 2007.
The project also lays the foundation for future development with optimized internal logistics and increased automation and robotics, added the company.
Hepol TPE has its headquarters in Malmö, Sweden, and operates facilities in China, Germany, the United Kingdom and United States.